These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 905965)

  • 1. Anticoagulant activity of heparin: assay of bovine, human and porcine preparations by amidolytic and clotting methods.
    Teien AN; Abildgaard U; Höök M; Lindahl U
    Thromb Res; 1977 Aug; 11(2):107-17. PubMed ID: 905965
    [No Abstract]   [Full Text] [Related]  

  • 2. Inactivation of bovine and human thrombin and factor Xa by antithrombin III studied with amidolytic methods.
    Odegård OR; Abildgaard U; Lie M; Miller-Andersson M
    Thromb Res; 1977 Aug; 11(2):205-61. PubMed ID: 905972
    [No Abstract]   [Full Text] [Related]  

  • 3. Heparin, platelets and blood coagulation: implications for low-dose heparin prophylactic regimens in venous thrombosis.
    Han P; Ardlie NG
    Br J Haematol; 1974 Jun; 27(2):253-72. PubMed ID: 4843673
    [No Abstract]   [Full Text] [Related]  

  • 4. The anticoagulant effect of heparin + antithrombin III using purified fibrinogen as substrate.
    Andersen P; Godal HC
    Haemostasis; 1977; 6(6):329-38. PubMed ID: 611046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A low molecular weight heparin compared with unfractionated heparin.
    Thomas DP; Merton RE
    Thromb Res; 1982 Nov; 28(3):343-50. PubMed ID: 7179221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulant activities of lung and mucous heparins.
    Barrowcliffe TW; Johnson EA; Eggleton CA; Thomas DP
    Thromb Res; 1978 Jan; 12(1):27-36. PubMed ID: 644557
    [No Abstract]   [Full Text] [Related]  

  • 7. Antithrombin III. Theory and clinical applications. H. P. Smith Memorial Lecture.
    Seegers WH
    Am J Clin Pathol; 1978 Apr; 69(4):299-359. PubMed ID: 347919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulant action of heparin.
    Damus PS; Hicks M; Rosenberg RD
    Nature; 1973 Dec; 246(5432):355-7. PubMed ID: 4586320
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro and in vivo correlation of clotting protease activity: effect of heparin.
    Gitel SN; Stephenson RC; Wessler S
    Proc Natl Acad Sci U S A; 1977 Jul; 74(7):3028-32. PubMed ID: 268650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A differential effect of low-affinity heparin on the inhibition of thrombin and factor Xa by antithrombin.
    Nordenman B; Nordling K; Björk I
    Thromb Res; 1980 Feb 1-15; 17(3-4):595-600. PubMed ID: 7368180
    [No Abstract]   [Full Text] [Related]  

  • 11. Heparin from bovine intestinal mucosa: glycans with multiple sulfation patterns and anticoagulant effects.
    Tovar AM; Capillé NV; Santos GR; Vairo BC; Oliveira SN; Fonseca RJ; Mourão PA
    Thromb Haemost; 2012 May; 107(5):903-15. PubMed ID: 22437650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biophysical characteristics of anionic density-fractionated mucosal heparins in relation to potencies in anticoagulant and thrombin-inhibition assays.
    Hurst RE; van Dedem G; Settine JM
    Thromb Res; 1981 Jun 1-25; 22(5-6):633-43. PubMed ID: 7302907
    [No Abstract]   [Full Text] [Related]  

  • 13. Antithrombin in vertebrate species: conservation of the heparin-dependent anticoagulant mechanism.
    Jordan RE
    Arch Biochem Biophys; 1983 Dec; 227(2):587-95. PubMed ID: 6607710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin, antithrombin, and abnormal clotting.
    Rosenberg RD
    Annu Rev Med; 1978; 29():367-78. PubMed ID: 77142
    [No Abstract]   [Full Text] [Related]  

  • 15. The inhibition by heparin of the intrinsic pathway activation of factor X in the absence of antithrombin-III.
    Ofosu F; Blajchman MA; Hirsh J
    Thromb Res; 1980 Nov; 20(4):391-403. PubMed ID: 6782701
    [No Abstract]   [Full Text] [Related]  

  • 16. A heparin analogue with specific action on antithrombin III.
    Thomas DP; Lane DA; Michalski R; Johnson EA; Kakkar VV
    Lancet; 1977 Jan; 1(8003):120-2. PubMed ID: 64653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The different action of bovine and human factor VIII (anti-haemophilic globulin) on factor X consumption during coagulation].
    Mayer G; Mayer S; Waitz R
    Rev Fr Etud Clin Biol; 1969 Dec; 14(10):1028-31. PubMed ID: 5377890
    [No Abstract]   [Full Text] [Related]  

  • 18. Factor V and VIII activation "in vivo" during bleeding. Evidence of thrombin formation at the early stage of hemostasis.
    Jensen AH; Beguin S; Josso F
    Pathol Biol (Paris); 1976 Dec; 24 Suppl():6-10. PubMed ID: 796811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous inactivation of thrombin and factor Xa by AT-III: influence of heparin.
    Odegård OR; Lie M
    Thromb Res; 1978 Apr; 12(4):697-700. PubMed ID: 663903
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanism of the anticoagulant action of heparin.
    Björk I; Lindahl U
    Mol Cell Biochem; 1982 Oct; 48(3):161-82. PubMed ID: 6757715
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.